Kv Pharmaceutical Company

Premium Company Profile

Publication Date	April 2008
Publisher	Datamonitor
Product Type	Report
Pages	61
ISBN Number	not applicable
Product Code	DAT11485

Price

£265.00
approximately: $521 | €337

PDF

PRINT £315 ($619 | €400)

Order above formats by FAX

Summary

Introduction

KV Pharmaceutical is a fully integrated specialty pharmaceutical company that develops, manufactures, markets and acquires technology-distinguished branded and generic/non-branded prescription pharmaceutical products. The company received the FDA approval for Evamist in July 2007 for the treatment of moderate to severe vasomotor symptoms due to menopause.

Scope

Contains corporate strategy, value chain presence and SWOT Analysis Provides detailed business description, segment analysis, 5-year financial trends, key products and key competitors Includes information on suppliers/ partners, shareholding structure and key employees with biographies

Highlights

KV Pharmaceutical's product portfolio includes branded products that are marketed by its wholly owned subsidiary, Ther-Rx; and generic products which are marketed by ETHEX, its generic products marketing subsidiary. KV Pharmaceutical derives majority of its revenues from product sales of technologically distinguished generic drugs marketed through its subsidiary ETHEX, branded pharmaceuticals through its subsidiary Ther-Rx and value-added raw materials, including microencapsulated products through Particle Dynamics subsidiary. KV Pharmaceutical's major contributor to sales growth out to 2010 will be the sales of generic products marketed by its wholly owned subsidiary, ETHEX. ETHEX sales are expected to increase from $204 million to $389 million between 2006 and 2010.

Reasons to Purchase

Access all the important information and analysis on the company in a single report Understand company's strengths, weaknesses, opportunities and threats along with business strategy and value chain Gain access to company's adjusted five year financial data along with key ratios and market capitalization.

Content

Overview
Catalyst
Summary
- Company Structure
- Company Overview and Key Facts
- Business Description
- History
- Locations and Subsidiaries
- Company Financials
- Stock Market Performance
- P&l
- Balance Sheet
- Cash Flow
- Business Segment Performance
- Products & Services
- Marketed Products
- Pipeline Products
- Historical Product Sales
- Ac Forecast Product Sales
- Competitors and Strategic Business Relationships
- Top Competitors
- Key Suppliers
- Key Clients
- Shareholding Structure
- Strategy
- Company View
- Corporate Strategy
- SWOT Analysis
- Overview
- Strengths
- Weaknesses
- Opportunities
- Threats
- Value Chain Analysis
- Overview
- Product Development
- Manufacturing
- Sales
- Scorecard
- Overview
- Scorecard Analysis
- Key Employees
- List of Key Employees
- Financial and Operational Overview
- Financial and Operational Overview
- Appendix
- Ask The Analyst
- Datamonitor Consulting
- Disclaimer
Table of Figures
- Figure 1: Kv Pharmaceutical - Operating Revenue/Cost Analysis, 2002-2006 ($ Mn)
- Figure 2: Kv Pharmaceutical - Key Strategic Revenues, 2002-2006 ($ Mn)
- Figure 3: Kv Pharmaceutical - Key Strategic Revenues, 2006-2010 ($ Mn)
Table of Tables
- Table 1: Kv Pharmaceutical - Key Facts
- Table 2: Kv Pharmaceutical - Other Locations and Subsidiaries
- Table 3: Kv Pharmaceutical - Year-End Share Price and Market Capitalization, 2002-2006 ($)
- Table 4: Kv Pharmaceutical - Key Events Impacting Share Price Performance
- Table 5: Kv Pharmaceutical - Operating Revenue/Cost Analysis, 2002-2006 ($ Mn)
- Table 6: Kv Pharmaceutical - Operating Cost Ratio Analysis, 2002-2006 (% of Total Revenues)
- Table 7: Kv Pharmaceutical - Balance Sheet, 2002-2006 ($ Mn)
- Table 8: Kv Pharmaceutical - Cash Flow, 2002-2006 ($ Mn)
- Table 9: Kv Pharmaceutical - Revenue Breakdown, 2002-2006 ($ Mn)
- Table 10: Kv Pharmaceutical - Marketed Products
- Table 11: Kv Pharmaceutical - in-House Pipeline Products
- Table 12: Kv Pharmaceutical - Historical Product Sales, 2002-2006 ($ Mn)
- Table 13: Kv Pharmaceutical - Forecast Sales, 2006-2010 ($ Mn)
- Table 14: Kv Pharmaceutical - Key Competitors
- Table 15: Kv Pharmaceutical - Key Suppliers
- Table 16: Kv Pharmaceutical - Key Shareholders
- Table 17: Kv Pharmaceutical - SWOT Analysis Summary
- Table 18: Kv Pharmaceutical - Value Chain Analysis
- Table 19: Kv Pharmaceutical - Scorecard
- Table 20: Kv Pharmaceutical - Key Employees
- Table 21: Kv Pharmaceutical - Financial and Operational Overview